10/24/2011 9:02:26 AM
SAN ANTONIO--(BUSINESS WIRE)--Phyton Biotech GmbH, an affiliate of Phyton, Ltd., announced today that it has filed a patent infringement lawsuit in the Federal Republic of Germany against Samyang Corporation, including its subsidiary Samyang Genex Corporation. The core issue of the lawsuit is Samyang’s use of enhanced plant cell fermentation technology using cell lines derived from Taxus species to produce paclitaxel. Phyton developed, patented, and commercialized plant cell fermentation technology, and believes Samyang’s paclitaxel production system is infringing on Phyton’s patented technology.
comments powered by